<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="500">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05154643</url>
  </required_header>
  <id_info>
    <org_study_id>2018.235</org_study_id>
    <nct_id>NCT05154643</nct_id>
  </id_info>
  <brief_title>T1rho Imaging of Liver in Presence of Iron</brief_title>
  <official_title>Quantitative Rotating Frame Relaxometry for Early Detection of Liver Fibrosis in Presence of Hepatic Iron</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver T1rho is elevated in response to accumulation of extracellular matrix proteins during&#xD;
      fibrosis. The presence of hepatic iron overload; however, can shorten the T1rho value. With&#xD;
      proper correction, we can remove this confounding factor and improve the reliability of T1rho&#xD;
      for early diagnosis of liver fibrosis.&#xD;
&#xD;
      Patients with early-stage liver fibrosis confirmed by biopsy will be recruited at the Prince&#xD;
      of Wales Hospital (Hong Kong). Thirty patients and twenty healthy volunteers will be&#xD;
      recruited. The liver iron content will be measured using the established T2* MRI relaxometry.&#xD;
      Breathhold black blood T1rho relaxometry will be used to collect T1rho data. The measured&#xD;
      T1rho will be retrospectively corrected to remove the shortening effect caused by iron.&#xD;
&#xD;
      We will use ANOVA to compare the measurement with and without fibrosis. We will use Pearson&#xD;
      correlations between the disease state and the imaging measurements, and ROC analysis to&#xD;
      determine the diagnostic value of the proposed method.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The liver iron content will be measured using the established T2* MRI relaxometry</measure>
    <time_frame>one year</time_frame>
    <description>Breathhold black blood T1rho relaxometry will be used to collect T1rho data. The measured T1rho will be retrospectively corrected to remove the shortening effect caused by iron.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Liver Fibrosis</condition>
  <arm_group>
    <arm_group_label>patients with liver fibrosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The patients with liver fibrosis and healthy controls will be screened before receiving MR&#xD;
        exam.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between age 18 and age 55&#xD;
&#xD;
          -  Informed written consent obtained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to MRI such as the presence of metallic implants, claustrophobia and&#xD;
             pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Weitian Chen</last_name>
    <phone>3505 1036</phone>
    <email>wtchen@cuhk.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong, Prince of Wale Hospital</name>
      <address>
        <city>Hong Kong</city>
        <state>Shatin</state>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weitian Chen</last_name>
      <phone>3505 1036</phone>
      <email>wtchen@cuhk.edu.hk</email>
    </contact>
    <investigator>
      <last_name>Weitian Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 9, 2021</study_first_submitted>
  <study_first_submitted_qc>December 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2021</study_first_posted>
  <last_update_submitted>December 9, 2021</last_update_submitted>
  <last_update_submitted_qc>December 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Chen Weitian</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Quantitative rotating frame relaxometry, T1rho, early detection of liver fibrosis, hepatic iron</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

